Stock Market
Sientra Reports Q3 Revenue Below Estimates; Stock Value Declines
Sientra, a leading Irvine-based manufacturer specializing in implants and related products for breast augmentation and reconstruction surgery, witnessed a decline in its stock value following...
Kintara Therapeutics Faces Stock Dip After Disappointing VAL-083 Study Results
In a significant development, Kintara Therapeutics, a prominent biopharmaceutical entity specializing in the advancement of novel solid tumor cancer treatments, witnessed a dip in its...
Cardio Diagnostics Secures Innovation Technology Contract with Vizient
Cardio Diagnostics Holdings, a trailblazer in artificial intelligence-powered precision cardiovascular medicine tests, has announced the acquisition of an Innovation Technology contract from Vizient, the nation’s...
Avalo Therapeutics Completes Divestiture of 800 Series Assets to AUG Therapeutics
Avalo Therapeutics, a pioneering biotechnology company dedicated to the development of innovative treatments for immunological diseases, announced today the successful completion of the divestiture of...
October Sees Eurozone Inflation Weakest Since 2019, ECB Reconsiders Rates
Preliminary data released on Tuesday revealed that Eurozone inflation witnessed a significant dip in October, marking its feeblest rate in over two years. This decline,...
Fed’s Policy Decision: US Stocks Tread Cautiously in Anticipation
In a day marked by cautious movements, US stocks treaded carefully on Tuesday, bracing for the impending policy decision from the Federal Reserve. The S&P...
US Stocks Rally in Anticipation of Federal Reserve Announcement
After enduring a turbulent start to the week, US stocks made a robust recovery on Monday, fueled by investor optimism ahead of pivotal events, including...
Volatility Strikes: S&P 500 Lands in Correction Territory
The year 2023 has proven to be a turbulent one for the stock market, with the S&P 500 index (^GSPC) experiencing significant fluctuations in value....
BioXcel Therapeutics Secures Permanent J-Code for Groundbreaking IGALM Sublingual Film, Stock Surges
BioXcel Therapeutics, a pioneering biopharmaceutical entity leveraging artificial intelligence in the pursuit of revolutionary advancements in neuroscience medicine, announced today that the Centers for Medicare...
Conduit Pharmaceuticals Stock Surges Amidst Absence of News
Conduit Pharmaceuticals, the biopharmaceutical entity, witnessed an unexpected surge in its stock value on Monday, defying the absence of any noteworthy developments or announcements from...
